ADN vs ENT

ASX Basic Materials sector comparison — updated 14 Jul 2026 — Basic Materials sector

ADN

ANDROMEDA FPO [ADN]

45LOW

ENT

ENT METALS FPO [ENT]

49LOW

Score Breakdown

ADN ENT
Technical
51
23
Catalyst
52
56
Sentiment
50
50
Fundamental
85
46
Momentum
30
36
Risk Gate
35
32

Key Metrics

ADN Metric ENT
$32.4MMarket Cap$5.0M
7.3MAvg Volume (20d)1.6M
+0.0%Short InterestN/A
$0.02552-Week High$0.012
$0.00652-Week Low$0.002
+0.0%Daily Change-14.3%
$0.007Reference Price$0.003
-93.3%ROE-42.7%
N/AProfit MarginN/A

Active Signals

ADN Signals

●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (8 quarters)
●Pre-revenue with moderate cash ($10-30M)
●Piotroski F-Score weak (3/9, low-confidence approx)
●EPS estimates revised upward (+10pts)
●Near 52-week low (5% of range)
●Small-cap ($20-100M)

ENT Signals

●Trading below both moving averages — the trend is working against this one
●Volume surging at 12.4x normal while price falls — heavy selling pressure
●Volume-price trend suggests distribution — sellers may be sneaking out while price holds
●Volatility is expanding fast — choppy price action, so buckle up
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (2.0 quarters)
●Very high P/S ratio (478.3x)
●Piotroski F-Score weak (3/9, low-confidence approx)

Ask Scout AI to compare ADN and ENT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ADN vs EPM →ADN vs FBU →ADN vs FUL →ADN vs FXG →ADN vs GHM →
ADN Full Analysis → ENT Full Analysis → Basic Materials Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).